Dry Suspension Formulation Technology
To address the oral administration needs of pediatric patients, elderly populations, and patients with swallowing difficulties, Bostal has developed a proprietary dry suspension formulation technology platform to overcome limitations of conventional solid dosage forms, including poor administration convenience and low dissolution of poorly soluble drugs. The platform enables the development of dry suspension products featuring rapid dispersion, stable suspension, and precise drug release, meeting diverse clinical medication requirements.
